Global Home Global Home  
Print page

Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call

PETALUMA, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth quarter 2016, ended March 31, 2016, will be released after the U.S. markets close on June 16, 2016. The earnings release will be followed by a conference call at 1:30 p.m. PDT on June 16, 2016, to discuss fiscal fourth quarter and year end results.

Individuals interested in participating in the conference call may do so by dialing 877-303-7607 for domestic callers or 973-638-3203 for international callers.  Those interested in listening to the conference call live via the internet may do so at  Please log on approximately 30 minutes prior to the presentation in order to register and download the appropriate software.

A telephone replay will be available for seven days following the conclusion of the call by dialing 855-859-2056 for domestic callers, or 404-537-3406 for international callers, and entering conference code 11222664. A webcast replay will be available on the site at for one year following the call.

About Oculus Innovative Sciences, Inc.
Oculus Innovative Sciences is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company's products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at

Media and Investor Contact:

Oculus Innovative Sciences, Inc.Dan McFadden

VP of Public and Investor Relations

(425) 753-2105

Primary Logo

Source: Oculus Innovative Sciences, Inc.

News Provided by Acquire Media